» Articles » PMID: 29477269

Quality of Life, Behaviour and Attitudes Towards Actinic Keratosis in Spain: The PIQA Study

Overview
Date 2018 Feb 26
PMID 29477269
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study was aimed to examine patients' knowledge, behaviours and attitudes regarding actinic keratosis (AK) lesions and the impact of the disease on patients' quality of life (QoL).

Methods: Observational study of patients with AK lesions in Spain. QoL was evaluated with the validated version of Spanish AKQoL questionnaire. Skin self-examination, sun-exposure, habits and attitudes towards AK's treatment were recorded using different questionnaires. The adherence was assessed by means of the Morisky-Green test. Among other variables, QoL and adherence to treatment were compared by using Pearson's χ test and one-way ANOVA tests. Inferential analysis regarding such factors and length of treatment were also performed.

Results: A total of 1240 patients (73.6 [10.5] years old) were recruited. Overall, patients that showed higher levels of concern were also showed a higher impairment on QoL. AK had greater effects on women's QoL and those who performed skin self-examination, think that AK is a disease and/or believe that moisturizers can prevent skin aging (P<.05). Adherence and length of treatment were strongly related, since patients with treatments intended for <1week were more likely to show good adherence and complete remission of AK (Odds Ratio [95%CI]: 6.25 [4.55-8.33] and 2.63 [1.96-3.45]), respectively).

Conclusions: Concerns due to AK are mainly related to sex and to the consideration of AK as a disease. More concerned patients tend to have lower QoL and good adherence to treatment. Short length of treatment was associated with better adherence and complete remission of AK lesions.

Citing Articles

Epidemiology and Risk Factors of Actinic Keratosis. What is New for The Management for Sun-Damaged Skin.

Thamm J, Schuh S, Welzel J Dermatol Pract Concept. 2024; 14(3 S1).

PMID: 39133637 PMC: 11566825. DOI: 10.5826/dpc.1403S1a146S.


International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting.

Kohn A, Alavi A, Armstrong A, Babalola F, Garg A, Gottlieb A Dermatology. 2021; 238(3):430-437.

PMID: 34537770 PMC: 9153366. DOI: 10.1159/000518966.


Patient-reported outcomes of topical therapies in actinic keratosis: A systematic review.

Grada A, Feldman S, Bragazzi N, Damiani G Dermatol Ther. 2021; 34(2):e14833.

PMID: 33527673 PMC: 8047920. DOI: 10.1111/dth.14833.


Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization.

Piquero-Casals J, Morgado-Carrasco D, Gilaberte Y, Del Rio R, Macaya-Pascual A, Granger C Dermatol Ther (Heidelb). 2020; 10(5):903-915.

PMID: 32681454 PMC: 7477025. DOI: 10.1007/s13555-020-00425-4.